Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
MA Rocca, MP Amato, N De Stefano… - The Lancet …, 2015 - thelancet.com
In patients with multiple sclerosis (MS), grey matter damage is widespread and might
underlie many of the clinical symptoms, especially cognitive impairment. This relation …
underlie many of the clinical symptoms, especially cognitive impairment. This relation …
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
Neuropsychiatric abnormalities may be broadly divided in two categories: disorders of
mood, affect, and behavior and abnormalities affecting cognition. Among these conditions …
mood, affect, and behavior and abnormalities affecting cognition. Among these conditions …
The hippocampus in aging and disease: from plasticity to vulnerability
T Bartsch, P Wulff - Neuroscience, 2015 - Elsevier
The hippocampus has a pivotal role in learning and in the formation and consolidation of
memory and is critically involved in the regulation of emotion, fear, anxiety, and stress …
memory and is critically involved in the regulation of emotion, fear, anxiety, and stress …
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis
M Calabrese, F Agosta, F Rinaldi, I Mattisi… - Archives of …, 2009 - jamanetwork.com
Background Neuropsychological deficits in patients with multiple sclerosis (MS) have been
shown to be associated with the major pathological substrates of the disease, ie …
shown to be associated with the major pathological substrates of the disease, ie …
Cognitive impairment in multiple sclerosis–a review of current knowledge and recent research
T Grzegorski, J Losy - Reviews in the Neurosciences, 2017 - degruyter.com
Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system that is
characterised by inflammatory damage to the myelin sheath. Though often neglected …
characterised by inflammatory damage to the myelin sheath. Though often neglected …
Measurement and clinical effect of grey matter pathology in multiple sclerosis
JJG Geurts, M Calabrese, E Fisher… - The Lancet …, 2012 - thelancet.com
During the past 10 years, the intense involvement of the grey matter of the CNS in the
pathology of multiple sclerosis has become evident. On gross inspection, demyelination in …
pathology of multiple sclerosis has become evident. On gross inspection, demyelination in …
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients
Abstract Objective: Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the
human central nervous system. Although the clinical impact of gray matter pathology in MS …
human central nervous system. Although the clinical impact of gray matter pathology in MS …
Regional DTI differences in multiple sclerosis patients
Diffusion tensor imaging (DTI) measures have shown to be sensitive to white matter (WM)
damage in multiple sclerosis (MS), not only inside focal lesions but also in user-defined …
damage in multiple sclerosis (MS), not only inside focal lesions but also in user-defined …
The hippocampus in multiple sclerosis
Some of the clinical manifestations of multiple sclerosis, such as memory impairment and
depression, are, at least partly, related to involvement of the hippocampus. Pathological …
depression, are, at least partly, related to involvement of the hippocampus. Pathological …